Browsing by Author Horvath, Lisa

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 21 to 40 of 52 < previous   next >
Issue DateTitleAuthor(s)Citation
2012The GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancerBrown, Christopher; Gebski, Val; Horvath, Lisa; Hruby, George; Ackland, Stephen P.; Borg, M; Carroll, Susan; Cummins, Michelle M; et al, Various; Goldstein, David; Selva-Nayagam, Sid; Shapiro, Jeremy; Spry, Nigel.A.; van Hazel, Guy; Wratten, C.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Central Clinical School: MedicineThe GOFURTGO Study: AGITG Phase II Study of fixed dose rate gemcitabine-oxaliplatin integrated with concomitant 5FU and 3-D conformal radiotherapy for the treatment of localised pancreatic cancer, British Journal of Cancer, vol.106, 1, 2012,pp 61-69
2012High Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapyChatfield, Mark; Horvath, Lisa; Kench, James; Delprado, Warick; Haynes, Anne Maree; Henshall, Susan; Pe Benito, Ruth; Rasiah, Krishan K.; Savdie, Richard; Stricker, Phillip D.; Sutherland, Robert L.; Turner, Jennifer Jane; Clinical Schools; Central Clinical School: Medicine; School of Medical Sciences: PathologyHigh Gleason grade carcinoma at a positive surgical margin predicts biochemical failure after radical prostatectomy and may guide adjuvant radiotherapy, BJU International (Print), vol.109, 12, 2012,pp 1794-1800
2008Immunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse.Horvath, Lisa; Butler, Miriam S.; Byers, Sharon; Henshall, Susan M.; Horsfall, David J.; Kench, James; Marshall, Villis R; Reinboth, Betty J.; Ricciardelli, Carmela; Sakko, Andrew J.; Stahl, Jurgen; Stricker, Phillip D.; Sutherland, Robert L.; Tilley, Wayne D.; Central Clinical School: MedicineImmunohistochemical level of unsulfated chondroitin disaccharides in the cancer stroma is an independent predictor of prostate cancer relapse., Cancer Epidemiology, Biomarkers and Prevention, vol.17, 9, 2008,pp 2488-2497
2005Impact of fish-oil supplement on nutritional parameters, inflammation and chemotherapy induced toxicity in colorectal cancer (CRC) patients receiving FOLFIRI - A pilot studyBeale, Philip; Childs, A; Clarke, Stephen; Horvath, Lisa; Read, Jane; Smith, Nicole; Volker, Dianne; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Medicine Faculty Office; Molecular & Microbial BioscienImpact of fish-oil supplement on nutritional parameters, inflammation and chemotherapy induced toxicity in colorectal cancer (CRC) patients receiving FOLFIRI - A pilot study, JOURNAL OF CLINICAL ONCOLOGY 2005, vol.23,(16S (supplement)),2005,pp Abstract 8243 S789-S789
2015Implementing Intensity-modulated Radiotherapy with Simultaneous Integrated Boost for Anal Cancer: 3 Year Outcomes at Two Sydney InstitutionsCarroll, Susan; Horvath, Lisa; Hruby, George; Kneebone, Andrew; Solomon, Michael; Tse, R; Byrne, Christopher M.; Yates, A; Central Clinical School: The Sydney Cancer Centre; Central Clinical School: Medicine; Central Clinical School: Medicine; Northern Clinical School: Imaging; Central Clinical School: Surgery; Central Clinical School: The Sydney Cancer CentreImplementing Intensity-modulated Radiotherapy with Simultaneous Integrated Boost for Anal Cancer: 3 Year Outcomes at Two Sydney Institutions, Clinical Oncology, vol.27, 12, 2015,pp 700-707
2015INPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survivalGupta, Ruta; Horvath, Lisa; Kench, James; Chiam, K; Fedele, Clare; Giles, Graham; McLean, Catriona A.; Mitchell, Christina A.; Ooms, Lisa M; Rynkiewicz, Natalie; School of Medical Sciences: Pathology; Central Clinical School: Medicine; School of Medical Sciences: PathologyINPP4B is highly expressed in prostate intermediate cells and its loss of expression in prostate carcinoma predicts for recurrence and poor long term survival, The Prostate, vol.75, 1, 2015,pp 92-102
2016Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate CancerGupta, Ruta; Horvath, Lisa; Kench, James; Mahon, Kate; Bruce, Hannah; Haynes, Anne Marie; Lin, Hui-Ming; Savdie, Richard; Stricker, Phillip D; School of Medical Sciences: Pathology; Central Clinical School: Medicine; School of Medical Sciences: Pathology; School of Public Health: Public HealthLoss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer, The Prostate, vol.76, 16, 2016,pp 1491-1500
2016Loss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate CancerGupta, Ruta; Horvath, Lisa; Kench, James; Mahon, Kate; Bruce, Hannah; Haynes, Anne Marie; Lin, Hui-Ming; Savdie, Richard; Stricker, Phillip D; School of Medical Sciences: Pathology; Central Clinical School: Medicine; School of Medical Sciences: Pathology; School of Public Health: Public HealthLoss of AZGP1 as a Superior Predictor of Relapse in Margin-Positive Localized Prostate Cancer, The Prostate, vol.76, 16, 2016,pp 1491-1500
2005Lower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer.Horvath, Lisa; Kench, James; Lee, Cheok; Brenner, Phillip C.; Golovsky, David; Grygiel, John J.; Henshall, Susan M.; Kooner, Raji; O'Neill, Gordon F.A.; Stricker, Phillip D.; Sutherland, Robert L.; Central Clinical School: Medicine; School of Medical Sciences: Pathology; Central Clinical School: MedicineLower levels of nuclear beta-catenin predict for a poorer prognosis in localized prostate cancer., International Journal of Cancer, vol.113,(3),2005,pp 415-422
2014Methylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancerBoyer, Michael; Gurney, Howard; Horvath, Lisa; Mahon, Kate; Marx, Gavin; Stockler, Martin; Castillo, Lesley; Chatfield, Mark; Clark, Susan J.; Devaney, James; Mallesara, G; Molloy, Peter; Paul, Cheryl; Qu, W; Wykes, R J; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Central Clinical School: Medicine; School of Public Health: Public Health; Medicine; School of Public Health: NH&MRC Clinical Trials CentreMethylated Glutathione S-transferase 1 (mGSTP1) is a potential plasma free DNA epigenetic marker of prognosis and response to chemotherapy in castrate-resistant prostate cancer, British Journal of Cancer, vol.111, 9, 2014,pp 1802-1809
2016Mutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancerGrogan, Judith; Gupta, Ruta; Hayes, Vanessa; Horvath, Lisa; Kench, James; Chan, Eva K F; Haynes, Anne Marie; Jaratlerdsiri, Weerachai; Kalsbeek, Anton; Lyons, Ruth J.; Petersen, Desiree; Stricker, Phillip D; Central Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: PathologyMutational load of the mitochondrial genome predicts pathological features and biochemical recurrence in prostate cancer, Aging, vol.8, 11, 2016,pp 2702-2712
2017Neurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancerBoyle, Frances; Grimison, Peter; Horvath, Lisa; Kiernan, Matthew; Park, Susanna; Baron-Hay, S; Farrar, Michelle; Goldstein, David; Kandula, Tejaswi; Krishnan, Arun V.; Northern Clinical School: Medicine; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Medical Sciences: PhysiologyNeurophysiological and clinical outcomes in chemotherapy-induced neuropathy in cancer, Clinical Neurophysiology, vol.128, 7, 2017,pp 1166-1175
2017Optimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi surveyBoyle, Frances; Cox, Keith; Grimison, Peter; Horvath, Lisa; Kiernan, Matthew; Park, Susanna; Baron-Hay, S; Goldstein, David; Krishnan, Arun V; Lewis, C R; McCrary, J; Webber, K; Northern Clinical School: Medicine; Faculty of Nursing & Midwifery; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Medical Sciences: PhysiologyOptimal clinical assessment strategies for chemotherapy-induced peripheral neuropathy (CIPN): a systematic review and Delphi survey, Supportive Care in Cancer, vol.25, 11, 2017,pp 3485-3493
2016Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien LifehouseBeith, Jane; Bhadri, Vivek; Boyer, Michael; Grimison, Peter; Horvath, Lisa; Kao, Steven; McNeil, Catriona; Tattersall, Martin; Lomax, Anna; Thomas, David; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineOutcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse, Internal Medicine Journal, vol.46, 12, 2016,pp 1392-1398
2011Pathways of chemotherapy resistance in castration-resistant prostate cancerHorvath, Lisa; Mahon, Kate; Henshall, Susan M.; Sutherland, Robert L.; Central Clinical School: Medicine; School of Public Health: Public HealthPathways of chemotherapy resistance in castration-resistant prostate cancer, Endocrine-Related Cancer, vol.18, 4, 2011,pp R103-R123
2013Patterns of DNA mutations and ALK Rearrangement in Resected Node Negative Lung AdenocarcinomaBoyer, Michael; Horvath, Lisa; Kench, James; McCaughan, Brian; O'Toole, Sandra; Trent, Ronald; Yip, Po Yee; Yu, Bing; Cooper, Wendy; Kennedy, Catherine; Kohonen-Corish, Maija R.J.; Ng, Chiu Chin; Selinger, Christina; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Medical Sciences: Pathology; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Medicine; Medicine; Central Clinical School: MedicinePatterns of DNA mutations and ALK Rearrangement in Resected Node Negative Lung Adenocarcinoma, Journal of Thoracic Oncology, vol.8, 4, 2013,pp 408-414
2015PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinomaBoyer, Michael; Cooper, Wendy Anne; Horvath, Lisa; Kao, Steven; McCaughan, Brian; O'Toole, Sandra; Scolyer, Richard; Vilain, Ricardo; Yip, Po Yee; Yu, Bing; Kohonen-Corish, Maija R.J.; Madore, Jason; Selinger, Christina; Tran, Thang N.; Yearley, Jennifer H; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: Medicine; Central Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Pathology; Central Clinical School: Pathology; Medicine; Central Clinical School: MedicinePD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma, Lung Cancer, vol.89, 2, 2015,pp 181-188
2017Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancerHorvath, Lisa; Marx, Gavin; Stockler, Martin; Bastick, Patricia; Briscoe, Karen; Gurney, H; Lin, H; Mahon, Kate; Mallesara, Girish; Spielman, Calan; Swarbrick, A; Central Clinical School: Medicine; SAHCS: Medicine; NH&MRC Clinical Trials CentrePhase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer, British Journal of Cancer, vol.116, 8, 2017,pp 1002-1011
2006A phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer.Beale, Philip; Clarke, Stephen; Horvath, Lisa; Ong, S; Rivory, Laurent; Sharma, Raghwa; Central Clinical School: Medicine; Concord Clinical School: ANZAC Research Institute; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; MedicineA phase II study of fixed-dose capecitabine and assessment of predictors of toxicity in patients with advanced/metastatic colorectal cancer., British Journal of Cancer, vol.94,(7),2006,pp 964-968
2014Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancerBoyer, Michael; Horvath, Lisa; Kench, James; McCaughan, Brian; Yip, Po Yee; Cooper, Wendy; Kohonen-Corish, Maija R.J.; Lin, Betty P.C.; Central Clinical School: Medicine; Central Clinical School: Medicine; School of Medical Sciences: Pathology; Central Clinical School: Surgery; MedicinePhosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer, Journal of Clinical Pathology, vol.67, 4, 2014,pp 333-340